Experts discuss current and future reality of tests and vaccines in Brazil
The global COVID-19 crisis has alarmed governments and specialists around the world because of its impacts on health, the economy and social relations. FGV Projetos and the Brazilian Institute of Legal Studies on Infrastructure (IBEJI) are holding a series of digital roundtables to discuss different topics related to the pandemic. The next event will take place on April 9, at 5 pm. The theme will be “Tests and vaccines in Brazil: current reality and a vision of the future.”
The guest speakers will include Maurício Zuma, of Bio-Manguinhos, the Oswaldo Cruz Foundation’s pharmaceutical plant, who during his 43-year life has contributed to the fight against vaccine-preventable diseases in Brazil. The other guest is Arthur Couto, of the Brazilian Association of Public Sector Drug Makers (ALFOB). They will discuss present actions and future plans to make Brazil better able to cope with crises of this kind.
This has long been a central, high-priority subject for public health policies, both nationally and globally, and it is even more important due to the current pandemic. Furthermore, the ability to meet demand, expand vaccination coverage and introduce new vaccines is a strategic prerequisite for the strengthening and sustainability of these policies.
The event will discuss actions of fundamental importance to indicate safer ways to return to normal and finally win the race against this virus, not just now, but also in future. This subject is related to the country’s ability to carry out public testing and search for an effective vaccine in this fight.
As well as the guest speakers, the participants will include Luiz Carlos Guimarães Duque, the executive director of FGV Projetos, Charles Schramm, the executive manager of FGV Projetos, and Augusto Dal Pozzo, the president of IBEJI.
For more information and to sign up, click here.